Pseudomonas aeruginosa infection during long-term suppression treatment with tobramycin inhalation powder (TIP)

R. McCleave; Z. Li; G. Einarsson; M. Loebinger; J. Chalmers; S. Elborn; C. Haworth; J. McKenna; D. Fairley; D. Allen; M. Tunney; L. Sherrard

doi:10.1016/s1569-1993(22)00458-1

Pseudomonas aeruginosa infection during long-term suppression treatment with tobramycin inhalation powder (TIP)

R. McCleave, Z. Li, G. Einarsson, M. Loebinger, J. Chalmers, S. Elborn, C. Haworth, J. McKenna, D. Fairley, D. Allen, M. Tunney, L. Sherrard

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	P126
Pages (from-to)	S99-S100
Journal	Journal of Cystic Fibrosis
Volume	21
Issue number	Supplement 1
DOIs	https://doi.org/10.1016/s1569-1993(22)00458-1
Publication status	Published - 01 Jun 2022
Event	45th European Cystic Fibrosis Conference 2022 - Ahoy Centre, Rotterdam, Netherlands Duration: 08 Jun 2022 → 11 Jun 2022 https://www.ecfs.eu/rotterdam2022

Access to Document

10.1016/s1569-1993(22)00458-1Licence: Unspecified

Ciprofloxacin resistance in Pseudomonas aeruginosa from people with bronchiectasis
Li, Z. (Author), Sherrard, L. (Supervisor) & Tunney, M. (Supervisor), Dec 2024
Student thesis: Doctoral Thesis › Doctor of Philosophy
Phenotypic and genotypic characterisation of Pseudomonas aeruginosa isolates from people with bronchiectasis
McCleave, R. P. (Author), Sherrard, L. (Supervisor), Tunney, M. (Supervisor) & Einarsson, G. (Supervisor), Dec 2023
Student thesis: Doctoral Thesis › Doctor of Philosophy

File

Cite this

McCleave, R., Li, Z., Einarsson, G., Loebinger, M., Chalmers, J., Elborn, S., Haworth, C., McKenna, J., Fairley, D., Allen, D., Tunney, M., & Sherrard, L. (2022). Pseudomonas aeruginosa infection during long-term suppression treatment with tobramycin inhalation powder (TIP). Journal of Cystic Fibrosis, 21(Supplement 1), S99-S100. Article P126. https://doi.org/10.1016/s1569-1993(22)00458-1

@article{cf55ca474c04480aab30bd041bb9b411,

title = "Pseudomonas aeruginosa infection during long-term suppression treatment with tobramycin inhalation powder (TIP)",

author = "R. McCleave and Z. Li and G. Einarsson and M. Loebinger and J. Chalmers and S. Elborn and C. Haworth and J. McKenna and D. Fairley and D. Allen and M. Tunney and L. Sherrard",

year = "2022",

month = jun,

day = "1",

doi = "10.1016/s1569-1993(22)00458-1",

language = "English",

volume = "21",

pages = "S99--S100",

journal = "Journal of Cystic Fibrosis",

issn = "1569-1993",

publisher = "Elsevier B.V.",

number = "Supplement 1",

note = "45th European Cystic Fibrosis Conference 2022, ECFS 2022 ; Conference date: 08-06-2022 Through 11-06-2022",

url = "https://www.ecfs.eu/rotterdam2022",

}

McCleave, R, Li, Z, Einarsson, G, Loebinger, M, Chalmers, J, Elborn, S, Haworth, C, McKenna, J, Fairley, D, Allen, D, Tunney, M & Sherrard, L 2022, 'Pseudomonas aeruginosa infection during long-term suppression treatment with tobramycin inhalation powder (TIP)', Journal of Cystic Fibrosis, vol. 21, no. Supplement 1, P126, pp. S99-S100. https://doi.org/10.1016/s1569-1993(22)00458-1

TY - JOUR

T1 - Pseudomonas aeruginosa infection during long-term suppression treatment with tobramycin inhalation powder (TIP)

AU - McCleave, R.

AU - Li, Z.

AU - Einarsson, G.

AU - Loebinger, M.

AU - Chalmers, J.

AU - Elborn, S.

AU - Haworth, C.

AU - McKenna, J.

AU - Fairley, D.

AU - Allen, D.

AU - Tunney, M.

AU - Sherrard, L.

PY - 2022/6/1

Y1 - 2022/6/1

U2 - 10.1016/s1569-1993(22)00458-1

DO - 10.1016/s1569-1993(22)00458-1

M3 - Meeting abstract

SN - 1569-1993

VL - 21

SP - S99-S100

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

IS - Supplement 1

M1 - P126

T2 - 45th European Cystic Fibrosis Conference 2022

Y2 - 8 June 2022 through 11 June 2022

ER -

Pseudomonas aeruginosa infection during long-term suppression treatment with tobramycin inhalation powder (TIP)

Access to Document

Student theses

Ciprofloxacin resistance in Pseudomonas aeruginosa from people with bronchiectasis

Phenotypic and genotypic characterisation of Pseudomonas aeruginosa isolates from people with bronchiectasis

Cite this